Core Viewpoint - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following disappointing financial results and issues related to its acquisition of Pro-ficiency Holdings, Inc. [1][2][3] Company Overview - Simulations Plus is a software company focused on modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2] - The company acquired Pro-ficiency Holdings, Inc. in June 2024, aiming to double its total addressable market and enhance sales [2][3] Financial Performance and Issues - Simulations Plus claimed successful integration of Pro-ficiency and effective internal controls, but evidence suggests struggles with integration and control effectiveness [3] - On June 11, 2025, the company announced disappointing preliminary financial results for Q3 2025, attributing challenges to market uncertainties, leading to a stock price drop of over 24% [4] - The Q3 2025 financial results included a $77.2 million charge related to prior acquisitions, and the company dismissed its auditor Grant Thornton, citing unresolved matters regarding segment reporting and internal controls [5] Stock Market Reaction - Following the announcement of the impairment charge and auditor dismissal, Simulations Plus's stock fell nearly 26% from $17.47 to $12.97 per share [5]

Core Viewpoint - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following disappointing financial results and issues related to its acquisition of Pro-ficiency Holdings, Inc. [1][2][3] Company Overview - Simulations Plus is a software company focused on modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2] - The company acquired Pro-ficiency Holdings, Inc. in June 2024, aiming to double its total addressable market and enhance sales [2][3] Financial Performance and Issues - Simulations Plus claimed effective internal controls over financial reporting, but evidence suggests struggles with the integration of Pro-ficiency and ineffective internal controls [3] - On June 11, 2025, the company announced disappointing preliminary financial results for Q3 2025, attributing challenges to market uncertainties, leading to a stock price drop of over 24% [4] - The Q3 2025 financial results included a $77.2 million charge related to prior acquisitions, and the company dismissed its auditor Grant Thornton, citing unresolved matters regarding segment reporting and internal controls [5] Stock Market Reaction - Following the announcement of the impairment charge and auditor dismissal, Simulations Plus's stock fell nearly 26% from $17.47 to $12.97 per share [5]

Core Viewpoint - Simulations Plus, Inc. experienced a significant decline in share price, approximately 25%, following the announcement of a $67.3 million net loss for Q3 2025, which included a $77.2 million impairment charge and the dismissal of its independent auditor, Grant Thornton [1]. Financial Performance - The company reported a net loss of $67.3 million for Q3 2025, which was attributed to a $77.2 million impairment charge [1]. - The impairment charge involved adjusting the book value of its assets to align with current market values [4]. Auditor Dismissal - Simulations Plus terminated its engagement with Grant Thornton on July 9, 2025, after hiring the firm on April 15, 2025 [1][4]. - The company cited issues related to segment reporting and internal controls over financial reporting as reasons for the auditor change, stating that these matters could not be finalized for its May 31, 2025, quarterly report [5]. Investigation - Hagens Berman, a national shareholders rights firm, has initiated an investigation into whether Simulations Plus misled investors regarding its asset valuations and the reasons for dismissing Grant Thornton [2][3]. - Grant Thornton disputed Simulations Plus's account of the dismissal, indicating that it had raised specific concerns about the company's financial statements during its review [6]. Shareholder Actions - Shareholders who suffered substantial losses are encouraged to submit their losses to assist in the investigation [2][7].

Core Viewpoint - Simulations Plus, Inc. is under investigation for potential violations of federal securities laws following disappointing financial results and issues related to its acquisition of Pro-ficiency Holdings, Inc. [1][2][3] Company Overview - Simulations Plus is a software company focused on modeling and simulation tools for the pharmaceutical, biotechnology, and chemical industries [2]. - The company acquired Pro-ficiency Holdings, Inc. in June 2024, aiming to double its total addressable market and enhance sales [2][3]. Financial Performance and Issues - Simulations Plus claimed successful integration of Pro-ficiency and effective internal controls over financial reporting, which appears to be misleading as the company struggled with integration and lacked effective controls [3]. - On June 11, 2025, the company announced disappointing preliminary financial results for Q3 2025, attributing challenges to market uncertainties, leading to a stock price drop of over 24% [4]. - The Q3 2025 financial results included a $77.2 million charge related to prior acquisitions, and the company dismissed its auditor Grant Thornton, citing unresolved matters regarding segment reporting and internal controls [5]. Stock Market Reaction - Following the announcement of the impairment charge and auditor dismissal, Simulations Plus's stock fell nearly 26% from $17.47 to $12.97 per share [5].

ATLANTA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP) complied with federal securities laws. On July 14, 2025, Simulations Plus reported financial results for its third quarter fiscal 2025. The Company noted that it had recognized a one-time non-cash impairment charge of $77.2 million for the quarter, and that it had “implemented a strategic reorganization, transitioning from a business unit structu ...

Group 1 - The core issue involves potential violations of federal securities laws by Simulations Plus, Inc. due to allegations of providing misleading business information to investors [1] - Simulations Plus reported third fiscal quarter sales of $20.4 million, missing the consensus estimate by approximately $500,000, and experienced a net loss of $67.3 million compared to a net income of $3.1 million in the same period of 2024 [3] - Following the negative financial report, Simulations Plus's stock price dropped by $4.70 per share, or 25.76%, closing at $12.97 per share on July 15, 2025 [3] Group 2 - Simulations Plus is a life sciences software and consulting company that provides advanced biosimulation tools and consulting services to pharmaceutical and biotechnology companies globally [2] - The company has implemented workforce reductions and cost-cutting measures as part of an operational restructuring plan initiated in June 2025 [3]

Core Viewpoint - Simulations Plus, Inc. experienced a significant decline in share price following a substantial net loss and the dismissal of its independent auditor, raising concerns about asset valuations and corporate governance [1][2][4]. Financial Performance - The company reported a net loss of $67.3 million for Q3 2025, which included a $77.2 million impairment charge [1]. - The impairment charge was attributed to adjustments in the book value of assets to align with current market values [4]. Auditor Dismissal - Simulations Plus terminated its engagement with Grant Thornton on July 9, 2025, just a few months after hiring them on April 15, 2025 [1][4]. - The company cited issues related to segment reporting and internal controls over financial reporting as reasons for the auditor change, claiming no "reportable events" occurred [5]. Investigation - Hagens Berman, a national shareholders rights firm, has initiated an investigation into whether Simulations Plus misled investors regarding asset valuations and the reasons for the auditor's dismissal [2][7]. - Grant Thornton disputed the company's account, indicating that they had raised specific concerns during their review of the financial statements [6].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Simulations Plus, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Company Performance - Simulations Plus reported sales of $20.4 million for the third quarter of 2025, which is a 10% year-over-year increase but below the consensus estimate of $20.9 million [3]. - The company had previously released preliminary third-quarter sales figures in June, which were also lower than expectations, ranging from $19 million to $20 million compared to a consensus of $22.78 million [3]. - Following the earnings report, Simulations Plus stock price fell by 25.75% on July 15, 2025 [3]. Group 2: Legal Action - Rosen Law Firm is preparing a class action to seek recovery of investor losses for those who purchased Simulations Plus securities [2]. - Investors can join the prospective class action without any out-of-pocket fees through a contingency fee arrangement [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [4].

Core Insights - Simulations Plus, Inc. is under investigation for potential securities fraud and unlawful business practices involving its officers and directors [1] - The company reported disappointing financial results for Q3 2025, with sales of $20.4 million, a net loss of $67.3 million, and a diluted loss per share of $3.35, significantly down from a net income of $3.1 million and earnings per share of $0.15 in Q3 2024 [3] - Following the financial report, Simulations Plus's stock price dropped by $4.50, or 25.76%, closing at $12.97 per share [4] - The company revised its fiscal 2025 adjusted earnings guidance down to a range of $0.93 to $1.06, from a previous estimate of $1.07 to $1.20 [3] - A restructuring initiative was initiated in June 2025, which includes workforce reductions and cost-cutting measures aimed at improving operational efficiency [3]

Core Insights - Simulations Plus is under investigation for potential securities fraud and unlawful business practices [1] - The company reported third fiscal quarter sales of $20.4 million, missing the consensus estimate of $20.9 million, and incurred a net loss of $67.3 million, including a non-cash impairment charge of $77.2 million [2] - Following the financial report, Simulations Plus's stock price dropped by $4.50, or 25.76%, closing at $12.97 per share [3] - The company revised its fiscal 2025 adjusted earnings guidance down to $0.93 to $1.06 from a previous range of $1.07 to $1.20 [2] - A restructuring initiative was initiated in June, involving workforce reductions and cost-cutting measures to enhance operational efficiency [2]